GENEVA, July 9 -- SHANGHAI CHONGZHENG BIOTECHNOLOGY CO., LTD filed a patent application (CN2025/148278) for “NEW PHARMACEUTICAL USE OF N4-HYDROXYCYTIDINE AND DERIVATIVES THEREOF”. With publication no. WO/2026/145723, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/7068
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....